ICUMICRO

SeaStar Medical Holding Corporation

HealthcareBiotechnology
$5.07
$0.00(+6.51%)
52W$0.22
$5.38
Updated Jul 8, 02:00 AM
RSI70
RS Rating99/99
Beta1.10
Volatility132%
F-Score4/9
Mkt Cap$199M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

SeaStar Medical Holding Corporation is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 99), indicating clear outperformance against the broad market. Earnings growth of 80% provides fundamental context to the price action. However, price is extended 34% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
99
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.10
vs S&P 500
MARKET
52W Position
94%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$3.78
50 SMA > 100 SMA$3.42
100 SMA > 150 SMA$3.19
150 SMA > 200 SMA$3.84

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$3.45+46.91%ABOVE
50 SMA$3.78+34.16%ABOVE
100 SMA$3.42+48.14%ABOVE
150 SMA$3.19+59.11%ABOVE
200 SMA$3.84+32.06%ABOVE

Price Performance

1D+6.5%
1W+38.1%
1M+74.8%
3M+21.6%
6M+106.1%
YTD+92.7%
1Y+8.2%
3Y-27.9%
52-Week Trading Range94% from low
$5.07
52W Low$0.22
52W High$5.38

Technical Indicators

RSI (14)BULLISH
69.8
305070
Setup ScoreCOOL
2/10
Base depth: 55.0%

Risk Profile

Beta
1.10
52W Vol
132%
ATR
$0.43
Max DD (1Y)
-82%

Volume Analysis

Today
170.6K
50D Avg
89.9K
Vol Ratio
1.90x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+89%
$-1.10
Q3'25+88%
$-1.30
Q4'25+91%
$-0.80
Q1'26+80%
$-0.90
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:+235.51%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+88.17%

Stock Price CAGR

10 Years:-32.46%
5 Years:-54.39%
3 Years:-27.89%
1 Year:+8.24%

Return on Equity

10Y Avg:-295.2%
5Y Avg:-295.2%
3Y Avg:-295.2%
Last Year:-146.3%

Key Metrics

Market Cap$199M
Gross Margin95.7%
Net Margin-9.8%
Piotroski F-Score4/9

Frequently Asked Questions

Is ICU in an uptrend right now?

ICU has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is ICU overbought or oversold?

ICU's RSI (14) is 70. The stock is in neutral territory, neither overbought nor oversold.

Is ICU outperforming the market?

ICU has a Relative Strength (RS) Rating of 99 out of 99. Yes, ICU is a market leader, outperforming 99% of all stocks over the past 12 months.

Where is ICU in its 52-week range?

ICU is trading at $5.07, which is 94% of its 52-week high ($5.38) and 94% above its 52-week low ($0.22).

How volatile is ICU?

ICU has a Beta of 1.10 and 52-week volatility of 132%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.